A number of new granaticin type quinone antibiotics have been isolated from Streptomyces lateritius ATCC19913. Spectroscopic evidence is presented which has led to the structure elucidation of three newantibiotics and the chemicalrelationship betweenmembers of the granaticin series has been studied.
. One of them, MM44326, was found to be identical to the previously described granaticin Bx'2) but the five other metabolites are new membersof the series. The production, isolation, purification, physical and biological properties of the six antibiotics are discussed in part I3). This paper presents spectroscopic evidence for the structure elucidation of MM44325, MM44787 and MM44785. Although the structures of MM44786 and MM44788 have not been elucidated the physical data obtained on these metabolites defines them as previously undescribed membersof the series.
The chemical conversion of granaticin B into dihydrogranaticin B, granaticin A and granaticinic acid, and its oxidation to MT44330 are also described. The granaticins are a well-documentedseries of quinone antibiotics and are reported to have antibacterial, antitumour and antiprotozoal activities4 '5) . Their isolation has been reported from several sources including S. lateritius (granaticin A, dihydrogranaticin A and its methyl ester)6) , Streptomyces violaceoruber (granaticins A and B)2) , Streptomyces olivaceus (granaticin A)7) , Streptomyces litmogenes (granaticin A)5), Streptomyces thermoviolaceus WR-141 (granaticin A and dihydrogranaticin A)4) and a thermophilic streptomycete (granaticin A and granaticinic acid)8).
Structural Studies
All spectroscopic data were obtained on the free acid form of the quinone metabolites, which were all chloroform soluble. The acid forms were prepared by partitioning products from silica gel chromatography between chloroform and dilute hydrochloric acid.
MM44326 (Granaticin B) The IR and XHNMRspectra (see Tables 1 and 2 ) obtained on this red compound were consistent with those reported1'^for the quinone antibiotic granaticin B. Quinones are known to be readily reduced in the mass spectrometer when operating in the fast atom bombardment (FAB) mode and large (M+2H)+and (M+3H)+ions are observed in the case of quinones with low reduction potentials^. Such is the case with MM44326 (Table 3) , and indeed all the quinone antibiotics derived from this culture. The base peak in the positive ion spectrum was at m/z 447 corresponding to the Acid hydrolysis of granaticin B afforded granaticin A1*80 but under basic conditions concomitant f-lactone cleavage was also observed leading to the formation of granaticinic acid, a previously described^antibiotic isolated from Streptomyces sp. The secondary hydroxyl group at position 4' in the L-rhodinose unit of granaticin B was readily oxidised with pyridinium chlorochromate to give MT44330. Spectral data was consistent with the proposed structure. (Table 3 ) indicated a molecular weight of 560, two mass units higher than that found for granaticin B (MM44326). A comparison of the IR data (Table 1) obtained on these two compoundssuggests that in MM44325 the f-lactone unit has been replaced by a carboxylic acid group and these features are readily accommodated in the proposed structure, dihydrogranaticin B.
Dihydrogranaticin B is a previously undescribed antibiotic, although dihydrogranaticin A has been isolated by several groups4>6>7). Confirmation of the proposed structure for MM44325 comes from XHand 13C NMRstudies. In particular, the low-field 4-H at d 5.23 in the JH NMRspectrum of granaticin B (Table 2 ) has been replaced in MM44325 by an AB quartet at higher field and furthermore the observed^and 13C chemical shifts (Tables 2 and 4 ) are in close agreement with those reported4'7' 10) for the related compound dihydrogranaticin A.
Dihydrogranaticin B was prepared synthetically from granaticin B by sodium dithionite reduction followed by aerial oxidation. The lactone cleavage is readily understood in terms of a /3-elimination following initial reduction to the hydroquinone system.
MM44787
Whilst similar in many other respects the XHNMRspectrum (Table 2 ) of MM44787 featured two striking differences from that of a typical granaticin. One was the absence of signals associated with carbon atoms 15 and 16 of the dihydropyran ring and the second was the appearance of two signals, presumably olefinic, at about 6 ppm. A 1H-1H correlated spectroscopy NMRexperiment elucidated the relationship between the protons at positions 2, 3 and 4 and, since no unassigned signals remained, position 14 in the proposed structure must bear an oxygen atom in order to complywith a molecular weight of 532.
MM44785
Whilst the *H NMRspectral data (Table 2) on MM44785 indicated that it was closely related to the granaticins, its yellow colour suggested that the typical red dihydroxynaphthoquinone chromophore had been modified in some way. The carbonyl stretching frequency of 1760 cm"1 in the IR spectrum (Table 1) was not consistent with either a f-lactone or a free carboxylic acid and the presence of a VOL. XLI NO. 4 THE JOURNAL OF ANTIBIOTICS 517 250MHzand 13C NMRdata on a Bruker AM400 operating at 100MHz. TMSwas used as internal standard. FAB-MSwere obtained on a VGZABIF instrument and accurate mass measurements were determined by multi-channel analysis using a 1 1-250J data system.
Reduction of Granaticin B A stirred solution of granaticin B (15 mg) in THF (2 ml) was treated with an aqueous solution of sodium dithionite in water until a yellow colour persisted for a few moments. Continued stirring in the presence of air led to the development of a red colour. The reaction mixture was nowpartitioned between CHC13and water. The organic layer was dried (MgSOJ and evaporated to afford a solid (8 mg) which was chromatographed on silica gel. Initial elution with CHC13 -MeOH(10 : 1) followed by neat MeOHafforded a blue material which was converted into the acidic (red) form by partition between dilute HC1 and CHC13. The organic layer afforded dihydrogranaticin B as a red solid (5 mg). IR, *H MMR and TLCcharacteristics identical to those of authentic material. Acidic Hydrolysis of Granaticin B A stirred solution of granaticin B (23 mg) in a mixture of 5 m HC1 solution (2 ml) and THF (2 ml) was heated to 50~60°C for 1 hour. The solution was then diluted with CHC13and water and the organic layer dried (MgSO4) and evaporated to afford crude product. Chromatography on silica gel, eluting with CHC13-MeOH(9 :1~1 : 1) gave the product which was partitioned between CHC13 and dilute HC1 solution. The organic layer afforded pure granaticin A (14 mg). IR and XHNMR consistent with published data1' 5).
Basic Hydrolysis of Granaticin B
A stirred solution of granaticin B (18 mg) in 10% sodium hydroxide solution (1 ml) was heated to 60°C for 1.5 hours. The cooled solution was acidified with dilute HC1solution, saturated with salt, and extracted with CHC13. The organic layer was dried (MgSO4) and evaporated to afford crude product (14 mg). Chromatography on silica gel, eluting with CHC13-MeOH(4 : 1) gave granaticin A (3 mg). Continued elution with neat MeOHgave granaticinic acid (MT 44329) (6mg). After conversion to the acidic form (see above) this material gave IR and *H NMRdata that was consistent with published figures8).
Oxidation of Granaticin B
A stirred solution of granaticin B (20 mg) in dichloromethane was treated with pyridinium chlorochrornate (50 mg) and stirred at room temperature for 2 hours. This reaction mixture was then partitioned between CHC13and dilute HO. The organic layer was dried (MgSO4)and evaporated to afford a crude product which was chromatographed on silica gel. Elution with CHC13-MeOH(9 : 1) afforded MT44330 (3.3 mg) followed by recovered starting material (2 mg).
